COVID-19SARS-CoV-2Myocarditis has been reported as a possible clinical presentation or complication in patients with coronavirus disease (COVID)-19 due to SARS-CoV-2. Despite the alarm that this possibility generated among physicians, there is paucity of information about mechanisms, prevalence, ...
Biventricular failure and myocardial damage with elevation of cardiac biomarkers have been reported in COVID-19 patients, although histological demonstration of acute myocarditis has been rarely documented. Indeed while cardiac magnetic resonance findings include different patterns of myocardial involvement in...
Theheart has played a central roleinCOVID-19 since the beginning. Cardiovascular conditions are among the highest risk factors for hospitalization. A significant number of patients hospitalized withSARS-CoV-2infections have signs of heart damage, and many recover from infection with lasting cardiovasc...
During the current COVID-19 pandemic, the subject of myocarditis has started to attract more attention. COVID-19 is known to induce myocardial injury. Suggested mechanisms of myocardial injury, including myocarditis, in COVID-19 patients include cytokine storms induced by an imbalance in the ...
QuestionWhat is the long-term prognosis of myocarditis after COVID-19 mRNA vaccination and do clinical outcomes and medical management differ from myocarditis of other origins? FindingIn this nationwide cohort study including 4635 patients hospitalized for myocarditis in France during the first...
The increased risk among COVID-19 patients was most pronounced in under-16s, who saw a 37-fold increased risk of myocarditis compared to people of that age group who did not have the coronavirus. This was followed by over-75s, 65 to 74-year-olds, and 50 to 64-year-olds. ...
A case series of precipitous cardiac tamponade from suspected perimyocarditis in COVID-19 patients. J Geriatr Cardiol 2021; 18(5): 403−406. DOI: 10.11909/j.issn.1671-5411.2021.05.001. Citation: Please cite this article as: Kogler W, Omar M, Maaliki N, Patel S, Foldy S, Ruiz J....
All patients were male, 22 of 23 were on active duty, and the median age was 25 (range 20-51) years; 20 of the 23 cases occurred after receipt of a second dose of an mRNA COVID-19 vaccine.
A literature review was performed identifying 277 autopsied hearts across 22 separate publications of COVID-19 positive patients. The median age of the autopsy cohort was 75 and 97.6% had one or more comorbidities. Initial review of the data indicate that myocarditis was present in 20 hearts (...
In a large registry (using the TriNetX platform with anonymized electronic medical record (EMR) data coming mostly from about 50 sites, mostly from the USA), researchers found that out of 718,365 COVID-19 patients studied in the first 6 months of 2020, 35,820 (5.0%) had a new ...